Skip to main content
Follow Gene Therapy Net on X LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 
Gene Therapy Net Newsletter  
genetherapynetbanner468x60

News: FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer

The US Food and Drug Administration (FDA) has approved Ferring Pharma’s Adstiladrin (nadofaragene firadenovec-vncg) as the first gene therapy for the treatment of adult patients with non-muscle-invasive bladder cancer (NMIBC). The novel adenovirus vector-based gene therapy is specifically indicated for patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive NMIBC with carcinoma in situ (CIS) with or without papillary tumours and is to be administered into the patient's bladder once every three months. The FDA based its decision on a phase 3 multicentre clinical study in 157 patients with high-risk BCG-unresponsive NMIBC, 98 of whom had BCG-unresponsive CIS with or without papillary tumours and could be evaluated for response.

Read more…

­

Conference: Gene & Cell Therapy Aseptic Processing Technology 

The GENAP Summit: Aseptic Processing Technology | Gene & Cell Therapy (February 23–24, 2023) will overview regulatory updates and their implementation, main challenges and overcome consideration, new technologies and innovations to avoid mistakes and ensure safe highly potent aseptic production for both sides – manufacturer and patient. As for the GCT track we will be focussing on vector improvement for both ex vivo and in vivo approaches, dedicated sessions on CMC strategy, analytical development and qualification, product-related impurities and their link to quality, bioassays, comparability, stability, formulation, and the emergence of non-viral gene therapies.

Register now…

­

Conference: 6th Antigen-Specific Immune Tolerance Summit

The hotly anticipated 6th Antigen-Specific Immune Tolerance Summit taking place in Boston next month (February 27 – March 1, 2023) gathers 100+ immune tolerance experts in person for the first time since 2020. This meeting returns as the definitive industry-dedicated forum bringing you the latest discoveries, preclinical, translational, and early clinical developments on tolerogenic therapies.

Register now…

­

Conference: Next Generation CAR & T Cell Therapies

CAR, T, and emerging cell lines: improve the safety, efficacy and reach of your novel CAR modalities through translational science and cutting edge clinical data. Revolutionize your cell & gene engineering – ground breaking autologous, allogeneic and in vivo treatments for blood born and solid tumors. 
As a GeneTherapyNet affiliate, you are eligible to save 10% off any pass type! Please use discount code GeneTherapyNet10 at checkout to redeem this code. Register today for the Next Generation CAR & T Cell Therapies conference (February 27 - March 2, 2023) to lock in the best rates!

Register now…

­

Conference: Cell & Gene Therapy Research & Development Congress Asia

This international conference in Taiwan (March 7-8, 2023) will focus on the advances being made in cell and gene therapies which have rapidly become an integral and vital component of modern medicine. With more than 20 presentations across two days, this congress is providing a platform for leading biopharma and biotech leaders, academicians and researchers to discuss topics on emerging advances in the field of cell and gene therapy, the regenerative potential of stem cells, application of T- cells and Cart-T in the field of immuno-oncology, novel gene-editing tools and delivery methods, vector development, regulatory approaches, ethical considerations and more. For 10% discount code: sk/cgca23/10 valid till 31st Jan 2023

Register now…

­

Conference: 4th Supply Chain and Logistics for Cell Therapies Summit

As numerous therapies progress to commercial levels, there has never been a more important time to synergize supply and clinical efforts. Returning to Boston in March, the 4th Supply Chain & Logistics for Cell Therapies Summit (March 7-9, 2023) unites 120+ Supply Chain and Clinical Delivery experts, with a new Clinical Delivery & Operations content track. Hear 30+ case studies from 25+ expert speakers, and engage in 4+ hours of interactive audience discussion at the only meeting dedicated to streamlining and standardizing the cell and gene therapy supply chain.

Register now…

­

Conference: Targeted Intracellular Delivery Summit 

Next-generation protein and nucleic-acid based drugs acting intracellularly have undeniable potential for revolutionizing modern medicine. However, these state-of the art therapies have been massively hampered by their delivery to target tissues and cell entry.
With the boom of nanotechnology, LNP’s, EV’s, liposomes, polymers, inorganic & protein-based nanoparticles are rapidly taking drug-carrier systems to the next level, equipping drug developers to engage previously elusive intracellular targets.
As process comes thick and fast, it is timely for the Targeted Intracellular Delivery Summit (March 8-9, 2023) to arrive as your definitive meeting of 2023 to optimize your pipeline’s therapeutic index with novel delivery systems to overcome endosomal barriers in target cells.

Register now…

­

Conference: Bioprocessing Summit Europe

The Bioprocessing Summit Europe brings together 500+ bioproduction, analytical and formulation professionals to advance the manufacture, quality and control of biological and genetic therapies. This 3-day, 10 track meeting has quickly become a premier meeting in the European bioprocessing calendar and is regarded by many as “the fastest growing bioprocessing meeting in Europe” following record growth in 2022 – 350 to 500+ attendees - and a sold-out Exhibit Hall.
We look forward to seeing you in Barcelona, or online, 14-16 March 2023, with expanded content on cell and gene therapy CMC and manufacturing, educational training seminars and a vastly bigger Exhibit Hall.  

Register now…

­

Conference: ISBioTech 12th spring meeting

Join the International Society for Bioprocess Technology March 20–22, 2023 in Norfolk, Virginia USA for the 12th Spring Meeting! Designed for professionals who develop and produce biologics worldwide, this conference features three concurrent, highly-respected programs — Viral Vectors & Vaccines, Cellular Therapies, and Baculovirus Expression Technology — covering the latest technologies and best practices needed for safe, effective, and consistent products. 
ISBioTech meetings offer an unparalleled opportunity to meet and network with top scientists, engineers, and supply firms in the biotech industry. You’ll learn and share with the industry’s leading organizations as you hear from the individuals actually doing the work in labs and production suites. 
Live virtual access to talks, plus access to some recorded presentations following the conclusion of the meeting is included. Register by January 23rd at the reduced rate.

Register now…

­

Conference: 6th Annual Gene Therapy for Rare Disorders 2023 Summit

Overcome Regulatory, Clinical, Manufacturing & Pricing Bottlenecks to Progress Safer, Efficacious, Accessible Rare Gene Therapies From Early Clinical Development Through to Approval
The 6th Annual Gene Therapy for Rare Disorders 2023 Summit (March 20-23, 2023) remains devoted to showcasing the top case studies and strategic learnings from the past year. With an expert speaking faculty devoted to bringing safer and more effective gene therapies to rare disease patients, key questions will be answered on how best the field can overcome regulatory, clinical, manufacturing and pricing bottlenecks to progress gene therapies into and through the clinic.

Register now…

­

Conference: Reuters Pharma USA 2023

Patient-first. Collaborative. Data and insights driven. Digitally underpinned.
These are the qualities of a healthcare system that actively serves its purpose – yet instead, the US is hindered by mounting financial toxicity, unprecedented politicization of science and eroding public trust.   
To capitalize on three years of extraordinary momentum and lead healthcare’s reform, pharma must embody the traits that healthcare needs to thrive and restructure in pursuit of change. 
Seize the moment at Reuters Events: Pharma USA 2023 (March 28-29, 2023) to lead pharma’s internal revolution and drive this critical systemic transformation. Join North America’s visionary pharma changemakers, leading solution providers, patient experts and industry heavyweights to catapult commercial excellence, ingrain patient-first strategies into the heart of pharma’s fabric and heed the long-awaited rebirth of America’s healthcare system.  

Register now…

­

Upcoming conferences and meetings

  • 16 - 20 January 2023 - PepTalk 2023 - Cell & Gene Therapy tracks - San Diego, CA
  • 23 - 24 January 2023 - Transdermal and Microneedle Drug Delivery - London, UK
  • 24 - 26 January 2023 - Next Generation Ophthalmic Drug Delivery Summit - San Francisco, CA
  • 24 - 26 January 2023 - 2nd Annual mRNA-Based Therapeutics Summit - Berlin, Germany
  • 24 - 26 January 2023 - RNA-Enhanced Cell Therapies summit - Boston, MA
  • 30 January - 1 February 2023 - 2nd Allogeneic Cell Therapies Summit Europe - London, UK
  • 30 January - 1 February 2023 - 3rd TGF-β for Immuno-Oncology Drug Development Summit - San Francisco, CA
  • 31 January - 2 February 2023 - Viral Vector Process Development Summit - Boston, MA
  • 8 - 9 February 2023 - 14th Annual RNA Therapeutics - London, UK
  • 15 - 16 February 2023 - 6th Annual Cell & Gene Therapy Innovation Summit - Berlin, Germany
  • 21 - 23 February 2023 - Retinal Vascular Disease Drug Development Summit - Boston, MA
  • 21 - 23 February 2023 - 6th CAR-TCR Summit Europe - London, UK
  • 21 - 23 February 2023 - 11th Alzheimer’s & Parkinson’s Drug Development Summit - San Francisco, CA
  • 21 - 23 February 2023 - 3rd Annual Gene Therapy for Muscular Disorders Summit - Boston MA
  • 23 - 24 February 2023 - GENAP Summit 2023 - Gene & Cell Therapy Aseptic Processing Technology - Milan, Italy
  • 27 February - 1 March 2023 - 6th Antigen-Specific Immune Tolerance Summit - Boston, MA
  • 27 February - 2 March 2023 - Next Generation CAR & T Cell Therapies - San Diego, CA
  • 7 - 8 March 2023 - Cell & Gene Therapy Research & Development Congress Asia - Taipei, Taiwan
  • 7 - 9 March 2023 - 4th Supply Chain and Logistics for Cell Therapies Summit - Boston, MA
  • 8 - 9 March 2023 - Targeted Intracellular Delivery Summit - Boston, MA
  • 14 - 16 March 2023 - 6th Annual Bioprocessing Summit Europe - Barcelona, Spain
  • 20 - 22 March 2023 - 12th Spring Meeting of the International Society for BioProcess Technology - Norfolk, VA
  • 20 - 23 March 2023 - 6th Annual Gene Therapy for Rare Disorders 2023 Summit - Boston, MA
  • 28 - 29 March 2023 - Reuters Pharma USA 2023 - Cell and Gene Therapies - Philadelphia, PA
  • 28 - 29 March 2023 - International Bioprocessing and Biologics 2023 - Cell and Gene Therapies - Berlin, Germany
  • 28 - 30 March 2023 - 8th Innate Killer Summit - San Diego, CA
  • 28 - 30 March 2023 - 3rd Gene Therapy Comparability Summit - Boston, MA
  • 17 - 19 April 2023 - Advancing Gene Therapy 2023 - Boston, MA
  • 17 - 19 April 2023 - 2nd LNP Formulation & Process Development Summit 2023 - Gene Therapy delivery - Boston
  • 18 - 20 April 2023 - mRNA Process Development & Manufacturing Summit Europe - Frankfurt, Germany
  • 24 - 25 April 2023 - The Economist's Cell & Gene Therapy summit - Brussels, Belgium
  • 26 - 27 April 2023 - World Oncology Cell Therapy Congress USA - Boston, MA
  • 2 - 4 May 2023 - 4th Gene Therapy Analytical Development Europe Summit - London, UK
  • 8 - 10 May 2023 - ISBioTech Nucleic Acids meeting - Production of DNA and RNA Biotherapeutics - Savannah, GA
  • 10 - 12 May 2023 - Bioprocessing Events 2023 - Berlin, Germany
  • 16 - 18 May 2023 - 2nd Next Generation RNA Therapeutics Summit - Boston, MA
  • 17 - 20 May 2023 - American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting - Los Angeles, CA
  • 23 - 24 May 2023 - Global Biologics Cell and Gene Legal Summit - Brussels, Belgium
  • 23 - 25 May 2023 - World Orphan Drug Congress USA 2023 - Washington, D.C.
  • 12 - 13 June 2023 - Annual meeting of the Netherlands Society of Gene & Cell Therapy - Lunteren, The Netherlands
  • 24 – 27 October 2023 - Annual Congress of the European Society of Gene and Cell Therapy - Brussels, Belgium

 

Advertise on this site?